Diltiazem CD vs. Diltiazem T: Not Interchangeable Formulations
No, diltiazem CD (controlled-delivery/controlled-release) is NOT the same as diltiazem T (immediate-release tartrate). These are distinct formulations with different dosing frequencies, pharmacokinetic profiles, and cannot be substituted on a 1:1 basis without consideration of their release characteristics.
Key Differences Between Formulations
Dosing Frequency
- Immediate-release (IR) diltiazem: Requires dosing 3-4 times daily 1
- Controlled-release (CD/CR) diltiazem: Dosed once or twice daily depending on the specific formulation 2, 3
Pharmacokinetic Profile
The controlled-release formulation provides sustained drug delivery over 24 hours with less peak-to-trough fluctuation 4. Specifically:
- IR formulation: Rapid absorption with higher peak concentrations and shorter duration of action
- CR formulation: Slower, sustained release with plasma concentrations maintained more consistently, particularly showing approximately 75% of daytime AUC during nighttime hours, with concentrations rising slowly from about 6 hours after the evening dose 4
Clinical Equivalence and Conversion
Therapeutic Equivalence
Multiple studies demonstrate that when total daily doses are equivalent, both formulations provide similar clinical efficacy:
- Comparable antianginal effects in stable angina 2, 3, 5
- Similar reduction in anginal attacks and nitroglycerin consumption 3, 5
- Equivalent safety profiles 2, 5
Conversion Strategy
When converting from immediate-release to extended-release formulations 6:
- Convert mg-for-mg to the same total daily dose
- If exact dose unavailable, use the next higher 120 mg dose
- Direct conversion is safe and effective without titration period
- Patients actually showed statistically significant decreases in angina frequency and nitroglycerin use after conversion 6
Practical Prescribing Considerations
Starting Doses by Indication
For angina pectoris 1:
- IR formulation: Start 30 mg four times daily, titrate gradually at 1-2 day intervals
- Optimal range: 180-360 mg/day in divided doses
- CR formulation: 120-360 mg daily in single or divided doses 7
Advantages of CR Formulation
The controlled-release formulation offers:
- Improved compliance with once or twice-daily dosing
- Better overnight coverage: More effective at preventing myocardial ischemia 12 hours after tablet intake compared to standard formulation 3
- Reduced dosing burden while maintaining therapeutic efficacy
Critical Safety Note
Regardless of formulation, diltiazem carries the same precautions 8, 7:
- Contraindicated in AV block greater than first degree (without pacemaker)
- Avoid in decompensated systolic heart failure
- Use caution with hypotension, hepatic/renal dysfunction
- Significant CYP3A4 interactions (diltiazem is both substrate and moderate inhibitor)
- Never combine with beta-blockers without extreme caution due to risk of profound AV nodal effects and cardiac contractility depression 9
Bottom Line
These are different pharmaceutical formulations requiring different dosing schedules. While they contain the same active ingredient and achieve similar therapeutic outcomes at equivalent total daily doses, they are not interchangeable without adjusting the dosing frequency. When converting between formulations, use the same total daily dose but adjust the frequency appropriately: IR requires 3-4 times daily dosing, while CD/CR allows once or twice daily administration.